Trajan Scientific
HemaPEN
2018
ISO 13485:2016 — Research, Concept, Development + Production
HEMAPEN®
The hemaPEN® is a convenient and accurate blood collection and dispensing platform that is designed to enable the collection of accurate micro-samples. hemaPEN® employs a capillary collection method with the intent to dispense an accurate volume of blood onto specialised filter paper.
Integrated compartments protect samples at every stage of the process and, following blood collection, the device can then be sent via regular mail to the laboratory for analysis.
Enhanced user experience.
hemaPEN® features a unique hand-held pen design that is convenient and easy to use while offering a new collection experience for users — it's possible that hemaPEN® will be used by both healthcare and non-healthcare professionals.
The transparent tip allows users to visually confirm completion of sample collection. A post-collection locking feature restricts sample extraction to trained laboratory staff. hemaPEN® has the potential to redefine blood collection, storage and transport.
Trajan’s hemaPEN® included on TGA’s ARTG as first blood microsampling device for use in Australia
Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). hemaPEN® has been listed - US FDA, Europe, UK + Australia. The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the clinical setting, to drive information-rich healthcare decision making. hemaPEN® is a registered trade mark owned by Trajan Scientific Australia Pty Ltd. hemaPEN® from Trajan Scientific and Medical. For more information + registration status in major markets please visit: www.hemapen.com